Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I G Kerr

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Annals of Internal Medicine|April 1, 1988
Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatientsI G Kerr, M Sone, C Deangelis, et al.
Investigational New Drugs|January 1, 1987
Phase I and pharmacokinetic study of high volume intraperitoneal aclacinomycin-A (Aclarubicin)I G Kerr, S Archer, C DeAngelis, et al.
Cancer Research|November 1, 1984
Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkeyI G Kerr, S Zimm, J M Collins, et al.
Journal of Palliative Care|January 1, 1990
Inpatient narcotic infusions for patients with cancer painF D Ferris, I G Kerr, C De Angelis, et al.
Canadian Family Physician Medecin De Famille Canadien|January 15, 2011
Subcutaneous infusion of analgesics: commentI G Kerr, C Deangelis, F Ferris, et al.
Clinical Pharmacology and Therapeutics|January 1, 1983
Test dose for predicting high-dose methotrexate infusionsI G Kerr, J Jolivet, J M Collins, et al.
Journal of Clinical Epidemiology|January 1, 1991
A cost-minimization study of cancer patients requiring a narcotic infusion in hospital and at homeF D Ferris, H B Wodinsky, I G Kerr, et al.
Gynecologic Oncology|May 24, 2001
Positron emission tomography for the evaluation of metastases in patients with carcinoma of the cervix: a retrospective reviewI G Kerr, M F Manji, J Powe, et al.
Cancer Research|December 1, 1991
Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole, CI-937 (DUP937)C Erlichman, M Moore, I G Kerr, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 15, 1987
Re-evaluating the cost of outpatient cancer chemotherapyH B Wodinsky, C DeAngelis, J J Rusthoven, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Annals of Internal Medicine|April 1, 1988
Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatientsI G Kerr, M Sone, C Deangelis, et al.
Investigational New Drugs|January 1, 1987
Phase I and pharmacokinetic study of high volume intraperitoneal aclacinomycin-A (Aclarubicin)I G Kerr, S Archer, C DeAngelis, et al.
Cancer Research|November 1, 1984
Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkeyI G Kerr, S Zimm, J M Collins, et al.
Journal of Palliative Care|January 1, 1990
Inpatient narcotic infusions for patients with cancer painF D Ferris, I G Kerr, C De Angelis, et al.
Canadian Family Physician Medecin De Famille Canadien|January 15, 2011
Subcutaneous infusion of analgesics: commentI G Kerr, C Deangelis, F Ferris, et al.
Clinical Pharmacology and Therapeutics|January 1, 1983
Test dose for predicting high-dose methotrexate infusionsI G Kerr, J Jolivet, J M Collins, et al.
Journal of Clinical Epidemiology|January 1, 1991
A cost-minimization study of cancer patients requiring a narcotic infusion in hospital and at homeF D Ferris, H B Wodinsky, I G Kerr, et al.
Gynecologic Oncology|May 24, 2001
Positron emission tomography for the evaluation of metastases in patients with carcinoma of the cervix: a retrospective reviewI G Kerr, M F Manji, J Powe, et al.
Cancer Research|December 1, 1991
Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole, CI-937 (DUP937)C Erlichman, M Moore, I G Kerr, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 15, 1987
Re-evaluating the cost of outpatient cancer chemotherapyH B Wodinsky, C DeAngelis, J J Rusthoven, et al.
Pageof 3